Activation of HIF-1α in the DCIS stage of BRCA1 or BRCA2 germline mutated patients would indicate that hypoxia is an early driver of BRCA mutation-related carcinogenesis. This evidence concerns the gene HIF1A and ductal breast carcinoma in situ.